Technology [ 11/13 ] | Scientific & Technical Instruments [ 115/159 ]
NYSE | Common Stock
Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally.
It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions.
The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries.
This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands.
The Precision Technologies segment offers electrical test and measurement, sensing and material technologies for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brand names.
The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands.
Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 24, 24 | 0.83 Increased by +10.67% | 0.79 Increased by +5.06% |
| Jan 31, 24 | 0.98 Increased by +11.36% | 0.94 Increased by +4.26% |
| Oct 25, 23 | 0.85 Increased by +7.59% | 0.85 |
| Jul 26, 23 | 0.85 Increased by +8.97% | 0.81 Increased by +4.94% |
| Apr 26, 23 | 0.75 Increased by +7.14% | 0.73 Increased by +2.74% |
| Feb 1, 23 | 0.88 Increased by +11.39% | 0.84 Increased by +4.76% |
| Oct 26, 22 | 0.79 Increased by +19.7% | 0.76 Increased by +3.95% |
| Jul 28, 22 | 0.78 Increased by +18.18% | 0.72 Increased by +8.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 1.52 B Increased by +4.37% | 207.4 M Increased by +19.47% | Increased by +13.6% Increased by +14.47% |
| Dec 31, 23 | 947.5 M Decreased by -38.07% | 265.2 M Increased by +16.73% | Increased by +27.99% Increased by +88.47% |
| Sep 30, 23 | 1.49 B Increased by +2.64% | 218 M Increased by +14.8% | Increased by +14.59% Increased by +11.84% |
| Jun 30, 23 | 1.53 B Increased by +4.31% | 209 M Increased by +20.81% | Increased by +13.69% Increased by +15.82% |
| Mar 31, 23 | 1.46 B Increased by +6.12% | 173.6 M Increased by +5.15% | Increased by +11.88% Decreased by -0.91% |
| Dec 31, 22 | 1.53 B Increased by +11.28% | 227.2 M Increased by +37.7% | Increased by +14.85% Increased by +23.74% |
| Sep 30, 22 | 1.46 B Increased by +12.04% | 189.9 M Increased by +25.93% | Increased by +13.04% Increased by +12.39% |
| Jun 30, 22 | 1.46 B Increased by +10.88% | 173 M Decreased by -4.37% | Increased by +11.82% Decreased by -13.75% |